Back

Prediabetes and glycemic transitions as determinants of frailty and functional decline in adults aged 50 years and older: A longitudinal analysis from five multinational aging cohorts

Malagon-Liceaga, A.; Basile-Alvarez, M. R.; Fermin-Martinez, C. A.; Ramirez-Rivera, D. L.; Perezalonso Espinosa, J.; Diaz-Sanchez, J. P.; Garcia-Gonzalez, S. B.; Carrillo-Herrera, K. B.; Cabrera-Quintana, L. A.; Antonio-Villa, N. E.; Gomes-Goncalves, N.; Garcia-Pena, C.; Bello-Chavolla, O. Y.

2026-04-24 geriatric medicine
10.64898/2026.04.22.26351540 medRxiv
Show abstract

Background: Prediabetes is highly prevalent in older adults and is characterized by heterogeneous clinical trajectories, including regression to normoglycemia and progression to diabetes. While prediabetes has been associated with impaired physical function and frailty, the longitudinal impact of both a single diagnosis and dynamic glycemic transitions on functional outcomes remains unclear. We aimed to evaluate associations between baseline prediabetes and glycemic transitions over time with trajectories of functional capacity and frailty in older adults. Methods: We conducted a pooled analysis of harmonized data from five nationally representative longitudinal aging cohorts (MHAS, HRS, CHARLS, ELSA, CRELES) within the Gateway to Global Aging Data, including adults aged [≥]50 years with [≥]1 HbA1c measurements. Prediabetes was defined per ADA criteria (HbA1c 5.7-6.4%). Functional outcomes included activities of daily living (ADL), instrumental ADL (IADL), and frailty assessed using Fried phenotype, FRAIL scale, and a deficit-accumulation Frailty Index (FI). Mixed-effects Poisson models estimated incidence rate ratios (IRRs) for baseline prediabetes, while generalized estimating equations assessed time-varying glycemic status and transition trajectories. Models were adjusted for age, sex, cohort, and time-varying covariates, with sensitivity analyses including BMI, smoking, and alcohol intake. Findings: Among 18,571 participants (median follow-up 13.6 years), baseline prediabetes was associated with increased progression of functional deficits and frailty compared with normoglycemia, including higher FI values and accelerated FI progression. Prediabetes was associated with higher incidence of ADL, IADL, and multimorbidity deficits from early follow-up, although time-dependent changes in incidence rates were not significant. In time-varying analyses (n=7,840), both prediabetes and diabetes were associated with higher incidence of functional deficits compared with normoglycemia, with diabetes showing the strongest effects across all outcomes. Diabetes was associated with greater FI burden and accelerated progression, whereas prediabetes showed a smaller increase, with attenuation over time. Among individuals with baseline prediabetes, regression to normoglycemia occurred in 20.8% and was associated with increased incidence of ADL and frailty deficits. In contrast, progression to diabetes occurred in 24.3%, and was associated with lower risk of incident ADL and Fried frailty deficits compared to stable prediabetes. Interpretation: Prediabetes is associated with increased risk of functional decline, frailty, and deficit accumulation in older adults, independent of progression to diabetes. Regression to normoglycemia was associated with higher risk of functional deterioration. These findings suggest that prediabetes reflects a state of metabolic vulnerability linked to biological aging rather than solely a precursor to diabetes and highlights a need to reframe its clinical significance in older populations. Funding: This research was supported by Instituto Nacional de Geriatria in Mexico. Keywords: Prediabetes; Glycemic transitions; Frailty; Functional decline; Aging; Multimorbidity

Matching journals

The top 3 journals account for 50% of the predicted probability mass.

1
The Journals of Gerontology: Series A
25 papers in training set
Top 0.1%
33.3%
2
The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences
22 papers in training set
Top 0.1%
14.5%
3
Journal of the American Geriatrics Society
12 papers in training set
Top 0.1%
7.2%
50% of probability mass above
4
npj Aging
15 papers in training set
Top 0.1%
6.4%
5
Alzheimer's & Dementia
143 papers in training set
Top 1.0%
6.4%
6
GeroScience
97 papers in training set
Top 0.3%
6.4%
7
Aging
69 papers in training set
Top 0.6%
4.0%
8
BMC Geriatrics
15 papers in training set
Top 0.2%
2.5%
9
Age and Ageing
27 papers in training set
Top 0.2%
2.1%
10
Aging Cell
144 papers in training set
Top 2%
1.9%
11
Journal of the American Medical Directors Association
13 papers in training set
Top 0.2%
1.3%
12
Experimental Gerontology
11 papers in training set
Top 0.2%
1.3%
13
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
38 papers in training set
Top 0.9%
1.1%
14
The Journal of Prevention of Alzheimer's Disease
10 papers in training set
Top 0.4%
0.7%
15
Nature Medicine
117 papers in training set
Top 5%
0.7%
16
Alzheimer's Research & Therapy
52 papers in training set
Top 2%
0.7%
17
Frontiers in Medicine
113 papers in training set
Top 8%
0.7%
18
eClinicalMedicine
55 papers in training set
Top 2%
0.7%
19
Translational Psychiatry
219 papers in training set
Top 4%
0.7%
20
Frontiers in Aging Neuroscience
67 papers in training set
Top 4%
0.7%
21
PLOS ONE
4510 papers in training set
Top 73%
0.5%
22
Frontiers in Aging
10 papers in training set
Top 0.6%
0.5%